Implicity ILR ECG Analyzer vs AVIEW
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A is designed for remote monitoring and arrhythmia detection from cardiac implantable devices, optimizing workflows for managing ECG data. Tool B, conversely, specializes in AI-driven analysis of CT scans for lung conditions and coronary artery calcification, streamlining diagnostic imaging workflows. While both operate in the cardiology AI space, their distinct focus on data types and clinical applications makes them suitable for different use cases.
Choose Implicity ILR ECG Analyzer if…
Choose Implicity ILR ECG Analyzer if your cardiology practice needs to significantly improve the efficiency and accuracy of remote monitoring for patients with cardiac implantable devices. This tool is ideal for reducing false positive alerts from ILRs, centralizing device data, and automating billing processes to optimize clinical workflows and enhance patient connectivity.
View Implicity ILR ECG Analyzer →Choose AVIEW if…
Choose AVIEW if your radiology or pulmonology department requires an advanced AI platform for comprehensive analysis of CT scans to detect and monitor lung cancer, COPD, and coronary artery calcification. This solution is best suited for enhancing diagnostic precision through automated nodule detection, emphysema quantification, and CAC scoring, while also streamlining reporting and integration with existing imaging systems.
View AVIEW →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Implicity ILR ECG Analyzer | AVIEW |
|---|---|---|
| Pricing | Contact vendor for pricing information. | Subscription; one-off payment |
| Deployment | Cloud-based / SaaS | Cloud-based; Hybrid solution; Locally on dedicated hardware; Locally virtualized (virtual machine, Docker) |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Implicity ILR ECG Analyzer | AVIEW |
|---|---|---|
| Name | Implicity ILR ECG Analyzer | AVIEW |
| Company | Implicity | Coreline Soft Co. |
| Description | Implicity's AI-powered platform provides smart remote monitoring solutions for cardiac implantable electronic devices (CIEDs) and implantable loop recorders (ILRs), enhancing arrhythmia detection and optimizing clinical workflows. | Coreline Soft's AVIEW AI platform offers comprehensive solutions for the early detection, diagnosis, and monitoring of lung cancer, COPD, and coronary artery calcification from CT scans, enhancing diagnostic precision and streamlining radiology workflows. |
| Primary Categories | Cardiology AI, Wearables & Remote Monitoring (RPM) | Cardiology AI, Oncology AI, Radiology & Imaging AI |
| Key Feature Example 1 | AI-Powered ILR ECG Analyzer: Reduces false positives by 79% for Medtronic ILRs while maintaining 99% sensitivity. | AI-powered lung nodule detection and characterization (size, volume, type, location, Lung-RADS score) |
| Key Feature Example 2 | Unified Device Data: Centralizes and standardizes all cardiac implantable device data. | Coronary artery calcium (CAC) scoring (Agatston, volume, mass score, risk stratification) |
Videos
Demos, reviews, and walkthroughs featuring Implicity ILR ECG Analyzer and AVIEW.
Loading videos…
Videos need JavaScript to load. Search YouTube directly →
Frequently Asked Questions
Implicity ILR ECG Analyzer focuses on AI-powered remote monitoring of cardiac implantable electronic devices (CIEDs) and implantable loop recorders (ILRs) to enhance arrhythmia detection and optimize clinical workflows. AVIEW, on the other hand, provides comprehensive solutions for the early detection, diagnosis, and monitoring of lung cancer, COPD, and coronary artery calcification from CT scans, enhancing diagnostic precision and streamlining radiology workflows.
Implicity ILR ECG Analyzer processes ECG data from implantable loop recorders and other cardiac implantable electronic devices to detect arrhythmias like asystole, bradycardia, and atrial fibrillation. AVIEW analyzes CT scan images to provide quantitative analysis of pulmonary tissue, lung nodules, emphysema, and coronary artery calcification.
Implicity's platform centralizes and standardizes all cardiac implantable device data, filters alerts with FDA-cleared algorithms, and automates billing and reporting. AVIEW integrates with PACS/RIS/CIS for automated analysis, 3D visualizations, and comprehensive PDF reports from CT scans, and supports follow-up registration for serial CT scans.
Implicity's AI-Powered ILR ECG Analyzer reduces false positives by 79% for Medtronic ILRs while maintaining 99% sensitivity, and decreases unnecessary AF alerts by 85%. AVIEW offers AI-powered lung nodule detection and characterization, emphysema quantification, and coronary artery calcium scoring to enhance diagnostic precision and can automate processing of lung and heart portions of a chest CT.
Implicity includes patient connectivity management, such as automated SMS to reconnect disconnected patients, and a dynamic billing engine designed for over 90% billing compliance. AVIEW primarily focuses on diagnostic features like automated segmentation, 3D visualizations, and follow-up registration for serial CT scans, with workflow automation within radiology.